This quality improvement project was inspired as an answer to a problem that intellectual disability teams have been struggling to manage whilst caring for people with epilepsy (PWE). The issue was that despite guidance to discuss the possibility of sudden unexpected death in epilepsy (SUDEP) be discussed with a newly diagnosed PWE this is rarely done. Additionally when, how, and what to discuss about SUDEP and reduce its risk is arbitrary, non-person centred, and with no structured evidence.
Problem
UK has 600,000 people with epilepsy (PWE), 30% being treatment resistant with a 42% sudden unexpected death in epilepsy (SUDEP) lifetime risk. Sudden death is 20 times higher in PWE to general population. Epilepsy is the 5th highest cause of life-years lost. Forty-two percent of deaths are considered avoidable. [1] Epilepsy NICE guidelines 2004 and 2012 [2] recommend discussion of SUDEP with newly diagnosed PWE. This is rarely followed and until recently only 4% PWE had a recorded SUDEP discussion. [3] In their current publication of the NHS Outcomes Framework, the Government prioritizes the prevention of amenable mortality, making it a core focus for NHS services. Epilepsy mortality features in new NICE Standards as well as NICE Clinical Guidelines. The public health burden of SUDEP alone is estimated as second only to stroke among neurological conditions. [4] However, the dilemma remains of when, how, and what to discuss about SUDEP. Meaningful structuring of its risk is arbitrary, nonperson centered with no evidenced mechanism.
At the two epilepsy services locally in Cornwall for people with intellectual disability (ID), as well as in the general population, the recorded discussion of SUDEP was less than 10%.
In Cornwall, the local community was motivated by the sudden unexpected death of a young nurse. Kt's Fund commissioned SUDEP Action to work in partnership with local researchers and epilepsy clinicians of Cornwall. A strong local partnership of stakeholders with input from national experts including specialists, general practitioners (GPs) and the HM Coroner has embraced this project. All PDSA cycles have involved local and national epilepsy experts, service users, national epilepsy charities, and GPs.
Background
There is a substantial body of work on SUDEP. [5, 6] While no definitive mechanism or factors have been categorically identified, research has shown that there are various factors which can influence risk of an adverse outcome. A detailed literature review was done to identify the nature of the problem and the available evidence. It concluded that evidence of risk factors exist but that this has not been brought together in a systemic manner to help patients, and that clinicians have a person centred discussion of individual risk.
In clinical practice the lack of any tools to support risk management is of concern. Risk management has been highlighted as vitally important to reducing avoidable epilepsy-related deaths, both in research and reporting, but also via prevention of future death reports and fatal accident inquiries held by those investigating sudden and unexpected deaths (www.sudep.org/epilepsy-deaths-reports).
A central theme of all these reports is a lack of awareness or underestimation of risk. In some places the idea that seizures are benign persists, a myth that was widespread in the 1990's. SUDEP occurs today in the context of the reduction of GPs Quality and Outcomes Framework (QOF) payments for epilepsy and in many areas pressures in hospitals to discharge patients early [7] all impacting on the care for those with epilepsy.
Baseline measurement
In 2010 a specialist epilepsy service of 350 complex PWE and ID were reviewed for any discussion on SUDEP. Less than 10% had a Page 1 of 4 recorded discussion of SUDEP. There was less than 1% of a recorded discussion of a person centred discussion of SUDEP looking into specific patient risk and characteristics in order to empower patents and their family to take safety measures. People with epilepsy want information on risk. [8, 9] While there is some evidence that communication of risk is improving, it is very slow. [10] 
Design
The team involves NHS Trusts, universities, primary and secondary care, international epilepsy experts, local specialists, GPs, national epilepsy charities, and service users.
The problem required a solution which was evidenced based, simple to use in a clinical setting, could be easily re-adopted across a range of settings and practices, and would be easy to communicate with patients/carers with clear outcomes for change. It also needed to be modifiable to change and lend itself to a range of applications.
A detailed literature review was undertaken to determine SUDEP contributory risk factors. A total of 18 factors were identified of which 11 were deemed modifiable and having the potential to influence the SUDEP risk. A SUDEP safety checklist [5, 6] 
Results
There have been zero sudden unexpected death in epilepsy in the ID epilepsy service in the last five years. This is from data at the coroners where every death that is epilepsy linked is now 
Lessons and limitations
The tool is used by epilepsy clinicians across Cornwall UK, dispersed to other parts of the UK (Plymouth, Birmingham, etc) and centres in New Zealand, France, Canada, Brazil, Netherlands, etc.
Publications were in the top five downloaded for the journal Seizure While there is no proven intervention or national surveillance of epilepsy mortality, the safety checklist is a simple and practical tool that can be used to demonstrate effective clinical and corporate governance while enhancing patient safety. It can also help give some assurance to bereaved families that every effort was made to reduce risk and prevent a fatality.
It also lends itself to a variety of templates such as paper A4 sheets, Excel format to monitor risk longitudinally, telehealth services and is being developed into a patient self-monitoring mobile app, EpsMon.
While the safety checklist was developed for SUDEP risk, factors such as non-adherence, depression, and substance misuse appear to closely overlap with the findings on risk from literature on all causes of epilepsy mortality. [14] [15] [16] The safety checklist, updated to take account of latest evidence, will be available in the spring of
2015.
The updated checklist is available from www.sudep.org. The
Checklist risk factors will be reviewed every two years by a committee of international experts in epilepsy brought together by SUDEP Action who would revisit the relevance of each risk factor as per current evidence and if appropriate recommend removal of out dated factors or addition of new relevant factors.
A peer reviewed editorial discussing the application of technology for PWE where in the SUDEP Checklist project utility is discussed has been accepted in the British Journal of General Practice. [17] The release of EpsMon would raise awareness of epilepsy risk among people with epilepsy who would then approach their health professionals to help them assess and understand risk. In addition the SUDEP checklist has been discussed to be part of the national commissioning tool kit for epilepsy to evidence safety. Promotional events and peer reviewed presentations at epilepsy conferences have been planned or conducted to increase awareness nationally and internationally.
